Antiretroviral therapyTHIERS, B. H.Journal of the American Academy of Dermatology. 1989, Vol 21, Num 3, pp 443-454, issn 0190-9622, 1Article

American-International conference on clinical dermatologyTHIERS, B. H.Journal of the American Academy of Dermatology. 1984, Vol 10, Num 2, pp 308-313, issn 0190-9622Article

Acyclovir in the treatment of herpesvirus infectionsTHIERS, B. H.Dermatologic clinics. 1990, Vol 8, Num 3, pp 583-587, issn 0733-8635, 5 p.Article

Articles selected from the nondermatologic literature of interest to dermatologists (January-December 1985)THIERS, B. H.Journal of the American Academy of Dermatology. 1986, Vol 15, Num 2, pp 265-274, issn 0190-9622, 1Article

Isoprinosine treatment of alopecia areataTHIERS, B. H.Journal of investigative dermatology. 1991, Vol 96, Num 5, pp 72S-73S, issn 0022-202XConference Paper

Dermatologic therapy in the 1980sTHIERS, B. H.Dermatologic clinics. 1988, Vol 6, Num 4, pp 609-625, issn 0733-8635Article

The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasisTHIERS, B. H.Journal of the American Academy of Dermatology. 1997, Vol 37, Num 3, pp S69-S71, issn 0190-9622, 2Conference Paper

Exogenous ochronosisSNIDER, R. L; THIERS, B. H.Journal of the American Academy of Dermatology. 1993, Vol 28, Num 4, pp 662-664, issn 0190-9622Article

Systemic Weber-Christian diseaseTER POORTEN, M. A; THIERS, B. H.Journal of cutaneous medicine and surgery. 2000, Vol 4, Num 2, pp 110-112, issn 1203-4754Article

In vitro suppression of human lymphocyte activity by minoxidilGALBRAITH, G. M. P; THIERS, B. H.International journal of dermatology. 1985, Vol 24, Num 4, pp 249-251, issn 0011-9059Article

Cryptosporidiosis in a patient receiving immunosuppressive therapy. Possible activation of latent infectionHOLLEY, H. P. JR; THIERS, B. H.Digestive diseases and sciences. 1986, Vol 31, Num 9, pp 1004-1007, issn 0163-2116Article

Dermatology therapy updateTHIERS, B. H.The Medical clinics of North America. 1998, Vol 82, Num 6, pp 1405-1414, issn 0025-7125Article

Cutaneous T-cell lymphoma and related disordersTHIERS, B. H; MAIZE, J. C.Dermatologic clinics. 1985, Vol 3, Num 4, pp 561-768, issn 0733-8635Serial Issue

Compounding is still appropriate in clinical practiceTHIERS, B. H.Dermatologic clinics. 1998, Vol 16, Num 2, issn 0733-8635, ix,329-330 [3 p.]Article

Therapeutic approaches in cutaneous lymphoma : Cutaneous lymphomasJÖRG, B; KERL, H; THIERS, B. H et al.Dermatologic clinics. 1994, Vol 12, Num 2, pp 433-441, issn 0733-8635Article

A new method for the comprehentive automatic morphologic image analysis of Langerhans cellsSAHN, E. E; THIERS, B. H; NICHOLSON, J. H et al.The American journal of dermatopathology. 1988, Vol 10, Num 5, pp 410-414, issn 0193-1091Article

A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalisGALBRAITH, G. M. P; THIERS, B. H; JENSEN, J et al.Journal of the American Academy of Dermatology. 1987, Vol 16, Num 5, pp 977-983, issn 0190-9622, 1Article

Gm allotype associated resistance and susceptibility to alopecia areataGALBRAITH, G. M. P; THIERS, B. H; PANDEY, J. P et al.Clinical and experimental immunology (Print). 1984, Vol 56, Num 1, pp 149-152, issn 0009-9104Article

Orbital multiple myeloma mimicking acquired angio-oedemaSNIDER, R. L; THIERS, B. H; HOWARD, G. R et al.British journal of ophthalmology. 1993, Vol 77, Num 7, pp 461-463, issn 0007-1161Article

An open-label trial of immunomodulation therapy with inosiplex (isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiencyGALBRAITH, G. M. P; THIERS, B. H; FUDENBERG, H. H et al.Journal of the American Academy of Dermatology. 1984, Vol 11, Num 2, pp 224-230, issn 0190-9622, 1Article

Mucipirocin resistanceTHIERS, B. H; HUDSON, I; WISE, R et al.Lancet (British edition). 1992, Vol 339, Num 8784, issn 0140-6736, p. 56Article

Physician drug dispensingLOBER, C. W; BEHLMER, S. D; PENNEYS, N. S et al.Journal of the American Academy of Dermatology. 1988, Vol 19, Num 5, pp 915-919, issn 0190-9622, part 1Article

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenailLING, M. R; SWINYER, L. J; MARTIN, A. G et al.Journal of the American Academy of Dermatology. 1998, Vol 38, Num 6, pp S95-S102, issn 0190-9622, 2Article

Immunological profiles in alopecia areataGALBRAITH, G. M. P; THIERS, B. H; VASILY, D. B et al.British journal of dermatology (1951). 1984, Vol 110, Num 2, pp 163-170, issn 0007-0963Article

The effect of aging and chronic sun exposure on human langerhans cell populationsTHIERS, B. H; MAIZE, J. C; SPICER, S. S et al.Journal of investigative dermatology. 1984, Vol 82, Num 3, pp 223-226, issn 0022-202XArticle